Abstract
Using a relatively dense genetic map of 72 single-nucleotide polymorphisms (SNPs) distributed across the entire 1.5-Mb locus on chromosome 22q11 associated with susceptibilit to schizophrenia1,2, we previously identified two subregions that were consistently associated with the disease3,4. In the distal subregion, we detected an association signal with five neighboring SNPs distributed over a haplotypic block of 80 kb encompassing six known genes4. One of these five SNPs, rs175174, had the strongest association of all 72 SNPs that we tested. Here we show that rs175174 regulates the level of the fully functional transcript by modulating the retention of intron 4 of the gene ZDHHC8, which encodes a putative transmembrane palmitoyltransferase. Zdhhc8-knockout mice had a sexually dimorphic deficit in prepulse inhibition, a gene dosage–dependent decrease in exploratory activity in a new environment and a decreased sensitivity to the locomotor stimulatory effects of the psychomimetic drug dizocilpine (MK801). SNP rs175174 shows differences in transmission distortion between sexes in individuals with schizophrenia. Our results indicate that there is an unexpected connection between impaired palmitate modification of neuronal proteins and the psychiatric phenotypes associated with microdeletions of chromosome 22q11.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others

References
Karayiorgou, M. et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. USA 92, 7612–7616 (1995).
Bassett, A.S. et al. The schizophrenia phenotype in 22q11 deletion syndrome. Am. J. Psychiatry 160, 1580–1586 (2003).
Liu, H. et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc. Natl. Acad. Sci. USA 99, 3717–3722 (2002).
Liu, H. et al. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc. Natl. Acad. Sci. USA 99, 16859–16864 (2002).
Dirksen, W.P., Sun, Q. & Rottman, F.M. Multiple splicing signals control alternative intron retention of bovine growth hormone pre-mRNA. J. Biol. Chem. 270, 5346–5352 (1995).
Huang, Y. & Carmichael, G.G. A suboptimal 5′ splice site is a cis-acting determinant of nuclear export of polyomavirus late mRNAs. Mol. Cell. Biol. 16, 6046–6054 (1996).
Kienzle, N. et al. Intron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genes. J. Virol. 73, 1195–1204 (1999).
Linder, M.E. & Deschenes, R.J. New insights into the mechanisms of protein palmitoylation. Biochemistry 42, 4311–4320 (2003).
Roth, A.F., Feng, Y., Chen, L. & Davis, N.G. The yeast DHHC cysteine-rich domain protein Akr1p is a palmitoyl transferase. J. Cell. Biol. 159, 23–28 (2002).
Lobo, S., Greentree, W.K., Linder, M.E. & Deschenes, R.J. Identification of a Ras palmitoyl-transferase in Saccharomyces cerevisiae. J. Biol. Chem. 277, 41268–41273 (2002).
El-Husseini, A.el-D. & Bredt, D.S. Protein palmitoylation: a regulator of neuronal development and function. Nat. Rev. Neurosci. 3, 791–802 (2002).
Swerdlow, N.R. & Geyer, M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr. Bull. 24, 285–301 (1998).
Gogos, J.A. et al. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat. Genet. 21, 434–439 (1999).
El-Husseini, A.el-D. et al. Synaptic strength regulated by palmitate cycling on PSD-95. Cell 108, 849–863 (2002).
Moghaddam, B. & Adams, B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281, 1349–1352 (1998).
D'Souza, D.N., Harlan, R.E. & Garcia, M.M. Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain. Neuroscience 93, 1539–1547 (1999).
Bateman, J.F., Freddi, S., Nattrass, G. & Savarirayan, R. Tissue-specific RNA surveillance? Nonsense-mediated mRNA decay causes collagen X haploinsufficiency in Schmid metaphyseal chondrodysplasia cartilage. Hum. Mol. Genet. 12, 217–225 (2003).
Drysdale, C.M. et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl. Acad. Sci. USA 97, 10483–10488 (2000).
Peltekova, V.D. et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 36, 471–475 (2004).
Aleman, A., Kahn, R.S. & Selten, J.P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch. Gen. Psychiatry 60, 565–571 (2003).
Leung, A. & Chue, P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr. Scand. Suppl. 401, 3–38 (2000).
Konnecke, R., Hafner, H., Maurer, K., Loffler, W. & an der Heiden, W. Main risk factors for schizophrenia: increased familial loading and pre- and peri-natal complications antagonize the protective effect of oestrogen in women. Schiz. Res. 44, 81–93 (2000).
Shifman, S. et al. A highly significant association between a COMT haplotype and schizophrenia. Am. J. Hum. Genet. 71, 1296–1302 (2002).
Hennah, W. et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum. Mol. Genet. 12, 3151–3159 (2003).
Jacquet, H. et al. PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. Hum. Mol. Genet. 11, 2243–2249 (2002).
Li, T. et al. Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population. Am. J. Med. Genet. published online 24 May 2004. (doi:10.1002/ajmg.b.30049).
Egan, M.F. et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA 98, 6917–6922 (2001).
Gogos, J.A., Osborne, J., Nemes, A., Mendelsohn, M. & Axel, R. Genetic ablation and restoration of the olfactory topographic map. Cell 103, 609–620 (2000).
Bunting, M., Bernstein, K.E., Greer, J.M., Capecchi, M.R. & Thomas, K.R. Targeting genes for self-excision in the germ line. Genes Dev. 13, 1524–1528 (1999).
Acknowledgements
We thank J. Keegan, C. Frazier and M. Monsey for technical support; P. Scheiffele for advice; and Y.-J. Chen for help in the initial phases of this project. This study was supported by grants from the US National Institute of Mental Health (to M.K. and J.A.G.) and the New York Academy of Sciences (to J.A.G.). J.A.G. is also the recipient of a McKnight Brain Disorders Award and a Vicente NARSAD Young Investigator.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Mukai, J., Liu, H., Burt, R. et al. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet 36, 725–731 (2004). https://doi.org/10.1038/ng1375
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ng1375

